pubmed-article:15301637 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15301637 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:15301637 | lifeskim:mentions | umls-concept:C0338656 | lld:lifeskim |
pubmed-article:15301637 | lifeskim:mentions | umls-concept:C1511790 | lld:lifeskim |
pubmed-article:15301637 | lifeskim:mentions | umls-concept:C0027902 | lld:lifeskim |
pubmed-article:15301637 | lifeskim:mentions | umls-concept:C1709061 | lld:lifeskim |
pubmed-article:15301637 | lifeskim:mentions | umls-concept:C0443131 | lld:lifeskim |
pubmed-article:15301637 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:15301637 | pubmed:dateCreated | 2004-8-10 | lld:pubmed |
pubmed-article:15301637 | pubmed:abstractText | In this investigation, the authors examined the classification accuracy of the Neuropsychological Assessment Battery-Screening Module (NAB-SM) in detecting the presence of general cognitive impairment among substance-abusing patients. The NAB-SM and the Neuropsychological Screening Battery (NSB), which has been shown to discriminate reliably between cognitively impaired and unimpaired substance-abusing patients, were each administered to 84 detoxified substance-abusing patients entering residential treatment. Using participants' performance on the NSB as the criterion measure, the authors found that 30 patients (36%) were cognitively impaired; using the NAB-SM, they classified 32 patients (38%) as cognitively impaired. Levels of agreement and diagnostic efficiency between the 2 batteries were excellent, suggesting the NAB-SM can discriminate accurately between cognitively impaired and unimpaired substance-abusing patients. | lld:pubmed |
pubmed-article:15301637 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15301637 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15301637 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15301637 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15301637 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15301637 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15301637 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15301637 | pubmed:language | eng | lld:pubmed |
pubmed-article:15301637 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15301637 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15301637 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15301637 | pubmed:month | Aug | lld:pubmed |
pubmed-article:15301637 | pubmed:issn | 1064-1297 | lld:pubmed |
pubmed-article:15301637 | pubmed:author | pubmed-author:Fals-StewartW... | lld:pubmed |
pubmed-article:15301637 | pubmed:author | pubmed-author:GrohmanKerryK | lld:pubmed |
pubmed-article:15301637 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15301637 | pubmed:volume | 12 | lld:pubmed |
pubmed-article:15301637 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15301637 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15301637 | pubmed:pagination | 200-7 | lld:pubmed |
pubmed-article:15301637 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:15301637 | pubmed:meshHeading | pubmed-meshheading:15301637... | lld:pubmed |
pubmed-article:15301637 | pubmed:meshHeading | pubmed-meshheading:15301637... | lld:pubmed |
pubmed-article:15301637 | pubmed:meshHeading | pubmed-meshheading:15301637... | lld:pubmed |
pubmed-article:15301637 | pubmed:meshHeading | pubmed-meshheading:15301637... | lld:pubmed |
pubmed-article:15301637 | pubmed:meshHeading | pubmed-meshheading:15301637... | lld:pubmed |
pubmed-article:15301637 | pubmed:meshHeading | pubmed-meshheading:15301637... | lld:pubmed |
pubmed-article:15301637 | pubmed:meshHeading | pubmed-meshheading:15301637... | lld:pubmed |
pubmed-article:15301637 | pubmed:meshHeading | pubmed-meshheading:15301637... | lld:pubmed |
pubmed-article:15301637 | pubmed:meshHeading | pubmed-meshheading:15301637... | lld:pubmed |
pubmed-article:15301637 | pubmed:meshHeading | pubmed-meshheading:15301637... | lld:pubmed |
pubmed-article:15301637 | pubmed:meshHeading | pubmed-meshheading:15301637... | lld:pubmed |
pubmed-article:15301637 | pubmed:meshHeading | pubmed-meshheading:15301637... | lld:pubmed |
pubmed-article:15301637 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15301637 | pubmed:articleTitle | The detection of cognitive impairment among substance-abusing patients: the accuracy of the neuropsychological assessment battery-screening module. | lld:pubmed |
pubmed-article:15301637 | pubmed:affiliation | Research Institute on Addictions, University at Buffalo, The State University of New York, Buffalo, NY 14203, USA. grohman@ria.buffalo.edu | lld:pubmed |
pubmed-article:15301637 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15301637 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:15301637 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15301637 | lld:pubmed |